Liquid diet with new Crohn's treatment
Part of Digestive system clinical trials.
This trial tests whether adding a special liquid diet (partial enteral nutrition) to a new advanced Crohn's medication can help control disease better than the medication alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of Crohn's disease and are about to start a new advanced medication (like a biologic or JAK inhibitor).
- Your Crohn's is active—either you have symptoms (score >175) or you're on a steroid and struggling to reduce it, and you have high inflammation markers (calprotectin ≥300) or active disease seen on a scope or scan.
- You are not pregnant, breastfeeding, or have an ostomy or short gut syndrome.
- You can drink a special liquid formula (Kate Farms) and receive shipments at home.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a specially designed anti-inflammatory American diet can help control mild to moderate Crohn's Disease symptoms. Participants will follow a diet plan, with guidance from the research team, to see if it reduces inflammation and improves quality of life.
This study tests a special liquid diet (smoothie) to treat newly diagnosed Crohn's disease in children and young adults. It aims to understand how the diet works and if it can help reduce inflammation.
This study tests whether starting adalimumab along with partial enteral (tube or drink) nutrition helps control active Crohn’s disease. It may help reduce symptoms and inflammation compared with standard care alone.
This trial tests whether a special liquid-only diet (exclusive enteral nutrition) can help people with active Crohn's disease, including those with complications like fistulas or narrowing of the intestine. It aims to improve nutrition and reduce disease activity without medication.
This trial tests an experimental drug for people with moderate to severe Crohn's disease who haven't responded well to other treatments. The drug aims to reduce inflammation and may help improve symptoms.
This trial compares a steroid called prednisolone to a special diet (aCDED with PEN) for treating Crohn's disease flare-ups. It aims to see which approach helps improve quality of life.
Hear when a new Crohn's Disease, Active trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.